NVAX · Novavax Inc · Debt
$8.76
-1.22 (-12.22%)
At close · Nov 12
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Market Cap
$1.45B
Shares
165.01M
Volume · Nov 12
7.01M
Avg daily vol (3M)
6.74M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Read debt and covenant terms in your AI or your code through MCP and the API →Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current finance lease liabilities | 2026-09-30 | USD 1,650,000 | 10-Q filed 2026-11-05 |
| Long-term debt, including current maturities | 2026-09-30 | USD 292,088,000 | 10-Q filed 2026-11-05 |
| Noncurrent finance lease liabilities | 2026-09-30 | USD 1,525,000 | 10-Q filed 2026-11-05 |
1 filing observation remains unmatched and is excluded from instrument histories.
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
1 filing has incomplete source or extraction coverage. Verified observations are shown; missing observations do not establish that debt was unchanged.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
1000694
CUSIP
670002401
13F (30d)
181 filings
154 filers
Visit website
Investor relations